Partial thromboplastin time
61 results
1 - 61Partial thromboplastin time
Transfusion Therapy - Coagulation Studies
Russell viper venom time (dRVVT)
sugammadex
ISOLATED PROLONGATION OF PTT: LABORATORY EVALUATION
Transfusion Therapy - The Decision to Transfuse
BLEEDING DISORDERS, INHERITED: EVALUATION OF SUSPECTED INHERITED BLEEDING DISORDERS
Protamine
nusinersen
olaratumab
Heparin—Unfractionated
margetuximab
brigatinib
valdecoxib
fruquintinib
tafasitamab
ripretinib
melphalan
bazedoxifene/conjugated estrogens
velaglucerase alfa
tivozanib
tisotumab vedotin
drotrecogin
Anesthesia for Cardiac Surgery - Preoperative Assessment for Cardiac Surgery
factor ix (human)
aprotinin
Anesthesia for Spine Surgery - Blood Loss
protamine
Argatroban
hetastarch
emicizumab
anticoagulants
argatroban
antihemophilic factor
desirudin
BLEEDING DISORDERS: LABORATORY EVALUATION
tirofiban
avapritinib
Alteplase
Anesthesia for Obstetrics and Gynecology - Preeclampsia
heparin
Anesthesia for Trauma and Burns - Initial Evaluation of the Trauma Patient
tenecteplase
thrombolytics
desmopressin
piperacillin/tazobactam
anistreplase
urokinase
reteplase
streptokinase
alteplase
Normal Values of Common Laboratory Tests
UNDERLYING ASSUMPTIONS
Hematologic Tests, Diagnostic Interpretation
Mechanical Support of the Failing Heart